| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to pharmaceutical industry and medicine, and concerns a stable pharmaceutical composition of methylethylpyridinone hydrochloride in the form of an infusion solution containing methylethylpyridinone hydrochloride in the amount of 0.45-0.55 %, 12-aqueous disodium phosphate in the amount of 0.079-0.081 %, sodium hydrosulphite in the amount of 0.018-0.022 %, sodium chloride in the amount of 0.723-0.731 %, and water for injections, as well as a method for preparing it. ^ EFFECT: pharmaceutical composition possesses high storage stability; it is applicable for parenteral introduction in neurology and cardiology. ^ 2 cl, 4 ex |
